Back to Search
ANNAPOORNA KINI, M.D.
M.D.
Interventional Cardiology Physician
NPI: 1952343212IndividualAccepts Medicare
Specialties, Licenses & Credentials
Specialist
Specialist
Code: 174400000X
001629(NY)
Interventional Cardiology PhysicianPrimary
Internal Medicine — Interventional Cardiology
Code: 207RI0011X
240371(NY)
CMS Specialties
PrimaryCARDIOVASCULAR DISEASE (CARDIOLOGY)
Education
OTHER
Class of 1991
Clinical Trials (2)
2
Linked Trials
0
Recruiting
2
With Results
Research & Publications (20)
A transcriptomic model to predict increase in fibrous cap thickness in response to high-dose statin treatment: Validation by serial intracoronary OCT imaging.
PMID 31126891·EBioMedicine·2019
8-other
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease.
PMID 28304224·N Engl J Med·2017
4-observational
Intracoronary Imaging, Cholesterol Efflux, and Transcriptomes After Intensive Statin Treatment: The YELLOW II Study.
PMID 27989886·J Am Coll Cardiol·2017
3-trial
Efficacy and Tolerability of Evolocumab vs Ezetimibe in Patients With Muscle-Related Statin Intolerance: The GAUSS-3 Randomized Clinical Trial.
PMID 27039291·JAMA·2016
2-rct
The relationship among extent of lipid-rich plaque, lesion characteristics, and plaque progression/regression in patients with coronary artery disease: a serial near-infrared spectroscopy and intravascular ultrasound study.
PMID 25190072·Eur Heart J Cardiovasc Imaging·2015
4-observational
Changes in plaque lipid content after short-term intensive versus standard statin therapy: the YELLOW trial (reduction in yellow plaque by aggressive lipid-lowering therapy).
PMID 23644090·J Am Coll Cardiol·2013
4-observational
Changing outcomes and treatment strategies for wire induced coronary perforations in the era of bivalirudin use.
PMID 19496119·Catheter Cardiovasc Interv·2009
5-case
Serum creatinine ratio: a novel predictor of mortality after percutaneous coronary intervention in patients with normal and abnormal renal function.
PMID 19288579·Catheter Cardiovasc Interv·2009
8-other
Relation of high-density lipoprotein cholesterol to mortality after percutaneous coronary interventions in patients with low-density lipoprotein <70 mg/dl.
PMID 19166688·Am J Cardiol·2009
8-other
Bolus-only versus bolus + infusion of glycoprotein IIb/IIIa inhibitors during percutaneous coronary intervention.
PMID 18760134·Am Heart J·2008
4-observational
Comparison of coronary flow reserve and fractional flow reserve in patients with versus without diabetes mellitus and having elective percutaneous coronary intervention and abciximab therapy (from the PREDICT Trial).
PMID 18328843·Am J Cardiol·2008
3-trial
Coronary angiography, lesion classification and severity assessment.
PMID 16781935·Cardiol Clin·2006
6-review
Effectiveness of the stent pull-back technique for nonaorto ostial coronary narrowings.
PMID 16214450·Am J Cardiol·2005
8-other
Correlation of postpercutaneous coronary intervention creatine kinase-MB and troponin I elevation in predicting mid-term mortality.
PMID 14697460·Am J Cardiol·2004
8-other
Prediction of outcome after percutaneous coronary intervention for the acute coronary syndrome.
PMID 14693323·Am J Med·2003
4-observational
Postprocedure chest pain after coronary stenting: implications on clinical restenosis.
PMID 12570941·J Am Coll Cardiol·2003
8-other
Effectiveness of tirofiban, eptifibatide, and abciximab in minimizing myocardial necrosis during percutaneous coronary intervention (TEAM pilot study).
PMID 12208416·Am J Cardiol·2002
3-trial
Changing trends in incidence and predictors of radiographic contrast nephropathy after percutaneous coronary intervention with use of fenoldopam.
PMID 11950448·Am J Cardiol·2002
8-other
A protocol for prevention of radiographic contrast nephropathy during percutaneous coronary intervention: effect of selective dopamine receptor agonist fenoldopam.
PMID 11835641·Catheter Cardiovasc Interv·2002
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 5 E 98TH ST, 3RD FLOOR
NEW YORK, NY 10029 - Phone
- (212) 241-5586
Quick Facts
- NPI
- 1952343212
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 35
- Clinical Trials
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile